Myodac AQ 75mg Injection
By Myodac AQ
Rx
1ml Injection in a Vial

Composition
Diclofenac(75mg)

Manufacturer - Adroit Lifescience Pvt Ltd
Plot No. 33&34, Phase Iv, Bhatoli Kalan, Baddi, Distt-Solan

Expires on or after
October, 2025

liver
Caution for Liver - When using Myodac AQ 75mg Injection, it's important to be cautious if you have liver disease. Your doctor may need to adjust the dosage accordingly. It's advisable to consult your doctor before taking this medicine if you have liver issues. If you are advised to use Myodac AQ 75mg Injection for an extended period, regular monitoring of liver function tests is recommended especially in patients with liver disease.

kidney
Myodac AQ 75mg Injection should be used carefully in patients with kidney disease. It may require a dose adjustment. Consult your doctor.

alcohol
When taking Myodac AQ 75mg Injection, it is important to be cautious about consuming alcohol. It is recommended to consult your doctor for guidance.

driving
Caution while driving Myodac AQ 75mg Injection may cause headaches, blurred vision, dizziness, or drowsiness in some patients, affecting the ability to drive.

pregnancy
Myodac AQ 75mg Injection may pose risks to the developing baby during pregnancy. However, in rare life-threatening cases, a doctor may consider its use if benefits outweigh risks. Consult a doctor before use.

breastfeeding
Myodac AQ 75mg Injection is considered safe for breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | Phenylacetic acid Derivative |
Therapeutic Class | PAIN ANALGESICS |
Action Class | NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid) |
₹29
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024